−0.0144USD
−2.94 MUSD
0.00USD
294.78 M
About AMPLIA THERAPEUTICS LIMITED
Sector
Industry
CEO
Christopher J. Burns
Website
Headquarters
Melbourne
Founded
2013
ISIN
AU0000023822
FIGI
BBG00BNJ95P0
Amplia Therapeutics Ltd. is a medical biotechnology company, which engages in the development of drugs for potential use in multiple indications including oncology and chronic fibrosis. Its immuno-modulator microparticles technology can be used to induce the human immune system to fight certain cancers and infections, or modulate certain immune mechanisms implicated in autoimmune diseases such as multiple sclerosis. The company was founded by Christopher J. Burns on May 31, 2000 and is headquartered in Melbourne, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of INNMF is 0.1373 USD — it has increased by 67.64% in the past 24 hours. Watch Amplia Therapeutics Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Amplia Therapeutics Ltd. stocks are traded under the ticker INNMF.
INNMF stock has risen by 63.45% compared to the previous week, the month change is a 23.69% rise, over the last year Amplia Therapeutics Ltd. has showed a 153.55% increase.
INNMF reached its all-time high on Jan 26, 2017 with the price of 1.6000 USD, and its all-time low was 0.0120 USD and was reached on Nov 8, 2017. View more price dynamics on INNMF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
INNMF stock is 40.35% volatile and has beta coefficient of 0.73. Track Amplia Therapeutics Ltd. stock price on the chart and check out the list of the most volatile stocks — is Amplia Therapeutics Ltd. there?
Today Amplia Therapeutics Ltd. has the market capitalization of 24.03 M, it has decreased by −11.05% over the last week.
Yes, you can track Amplia Therapeutics Ltd. financials in yearly and quarterly reports right on TradingView.
INNMF net income for the last half-year is −2.20 M USD, while the previous report showed −726.55 K USD of net income which accounts for −202.84% change. Track more Amplia Therapeutics Ltd. financial stats to get the full picture.
No, INNMF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, INNMF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Amplia Therapeutics Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Amplia Therapeutics Ltd. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Amplia Therapeutics Ltd. stock shows the buy signal. See more of Amplia Therapeutics Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.